Literature DB >> 9573082

Identification of epitope and surface-exposed domains of Shigella flexneri invasion plasmid antigen D (IpaD).

K R Turbyfill1, J A Mertz, C P Mallett, E V Oaks.   

Abstract

Transport and surface expression of the invasion plasmid antigens (Ipa proteins) is an essential trait in the pathogenicity of Shigella spp. In addition to the type III protein secretion system encoded by the mxi/spa loci on the large virulence plasmid, transport of IpaB and IpaC into the surrounding medium is modulated by IpaD. To characterize the structural topography of IpaD, the Geysen epitope-mapping system was used to identify epitopes recognized by surface-reactive monoclonal and polyclonal antibodies produced against purified recombinant IpaD or synthetic IpaD peptides. Surface-exposed epitopes of IpaD were confined to the first 180 amino acid residues, whereas epitopes in the carboxyl-terminal half were not exposed on the Shigella surface. By using convalescent-phase sera from 10 Shigella flexneri-infected monkeys, numerous epitopes were mapped within a surface-exposed region of IpaD between amino acid residues 14 and 77. Epitopes were also identified in the carboxyl-terminal half of IpaD with a few convalescent-phase sera. Comparison of IpaD epitope sequences with Salmonella SipD sequences indicated that very similar epitopes may exist in the carboxyl-terminal region of each protein whereas the IpaD epitopes in the surface-exposed amino-terminal region were unique for the Shigella protein. Although the IpaD and SipD homologs may play similar roles in transport, the dominant serum antibody response to IpaD is against the unique region of this protein exposed on the surface of the pathogen.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9573082      PMCID: PMC108156          DOI: 10.1128/IAI.66.5.1999-2006.1998

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  32 in total

1.  Two novel virulence loci, mxiA and mxiB, in Shigella flexneri 2a facilitate excretion of invasion plasmid antigens.

Authors:  G P Andrews; A E Hromockyj; C Coker; A T Maurelli
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

2.  Characterization of invasion plasmid antigen genes (ipaBCD) from Shigella flexneri.

Authors:  M M Venkatesan; J M Buysse; D J Kopecko
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

3.  Local and systemic antibody responses to Shigella infection in rhesus monkeys.

Authors:  G Dinari; T L Hale; S W Austin; S B Formal
Journal:  J Infect Dis       Date:  1987-05       Impact factor: 5.226

4.  Requirement for exported proteins in secretion through the invasion-associated type III system of Salmonella typhimurium.

Authors:  C M Collazo; J E Galán
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

5.  Antibody response of monkeys to invasion plasmid antigen D after infection with Shigella spp.

Authors:  E V Oaks; W D Picking; W L Picking
Journal:  Clin Diagn Lab Immunol       Date:  1996-03

6.  Molecular cloning of invasion plasmid antigen (ipa) genes from Shigella flexneri: analysis of ipa gene products and genetic mapping.

Authors:  J M Buysse; C K Stover; E V Oaks; M Venkatesan; D J Kopecko
Journal:  J Bacteriol       Date:  1987-06       Impact factor: 3.490

7.  Shigella flexneri invasion plasmid antigens B and C: epitope location and characterization with monoclonal antibodies.

Authors:  J A Mills; J M Buysse; E V Oaks
Journal:  Infect Immun       Date:  1988-11       Impact factor: 3.441

8.  Serum immune response to Shigella protein antigens in rhesus monkeys and humans infected with Shigella spp.

Authors:  E V Oaks; T L Hale; S B Formal
Journal:  Infect Immun       Date:  1986-07       Impact factor: 3.441

9.  Contact of Shigella with host cells triggers release of Ipa invasins and is an essential function of invasiveness.

Authors:  M Watarai; T Tobe; M Yoshikawa; C Sasakawa
Journal:  EMBO J       Date:  1995-06-01       Impact factor: 11.598

10.  Interaction of Ipa proteins of Shigella flexneri with alpha5beta1 integrin promotes entry of the bacteria into mammalian cells.

Authors:  M Watarai; S Funato; C Sasakawa
Journal:  J Exp Med       Date:  1996-03-01       Impact factor: 14.307

View more
  11 in total

Review 1.  Surface organelles assembled by secretion systems of Gram-negative bacteria: diversity in structure and function.

Authors:  David G Thanassi; James B Bliska; Peter J Christie
Journal:  FEMS Microbiol Rev       Date:  2012-05-24       Impact factor: 16.408

2.  NMR model of PrgI-SipD interaction and its implications in the needle-tip assembly of the Salmonella type III secretion system.

Authors:  Thenmalarchelvi Rathinavelan; Maria Lara-Tejero; Matthew Lefebre; Srirupa Chatterjee; Andrew C McShan; Da-Chuan Guo; Chun Tang; Jorge E Galan; Roberto N De Guzman
Journal:  J Mol Biol       Date:  2014-06-18       Impact factor: 5.469

3.  Development and preclinical evaluation of a trivalent, formalin-inactivated Shigella whole-cell vaccine.

Authors:  R W Kaminski; M Wu; K R Turbyfill; K Clarkson; B Tai; A L Bourgeois; L L Van De Verg; R I Walker; E V Oaks
Journal:  Clin Vaccine Immunol       Date:  2014-01-08

4.  Minor nucleotide substitutions in the omp31 gene of Brucella ovis result in antigenic differences in the major outer membrane protein that it encodes compared to those of the other Brucella species.

Authors:  N Vizcaíno; R Kittelberger; A Cloeckaert; C M Marín; L Fernández-Lago
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

5.  IpaD of Shigella flexneri is independently required for regulation of Ipa protein secretion and efficient insertion of IpaB and IpaC into host membranes.

Authors:  Wendy L Picking; Hiroaki Nishioka; Patricia D Hearn; M Aaron Baxter; Amanda T Harrington; Ariel Blocker; William D Picking
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

6.  Formulation and immunogenicity studies of type III secretion system needle antigens as vaccine candidates.

Authors:  Brooke S Barrett; Aaron P Markham; Reza Esfandiary; Wendy L Picking; William D Picking; Sangeeta B Joshi; C Russell Middaugh
Journal:  J Pharm Sci       Date:  2010-11       Impact factor: 3.534

7.  Isolation and characterization of a Shigella flexneri invasin complex subunit vaccine.

Authors:  K R Turbyfill; A B Hartman; E V Oaks
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

8.  Characterization of immunodominant and potentially protective epitopes of Mannheimia haemolytica serotype 1 outer membrane lipoprotein PlpE.

Authors:  Sahlu Ayalew; Anthony W Confer; Emily R Blackwood
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

9.  IpaD localizes to the tip of the type III secretion system needle of Shigella flexneri.

Authors:  Marianela Espina; Andrew J Olive; Roma Kenjale; David S Moore; S Fernando Ausar; Robert W Kaminski; Edwin V Oaks; C Russell Middaugh; William D Picking; Wendy L Picking
Journal:  Infect Immun       Date:  2006-08       Impact factor: 3.441

10.  Macrophage Apoptosis Triggered by IpaD from Shigella flexneri.

Authors:  Olivia Arizmendi; William D Picking; Wendy L Picking
Journal:  Infect Immun       Date:  2016-05-24       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.